iComply: Reducing Product Liability through Compliance and Standards
Authored By: Mark Slaugh, CEO, iComply Product liability in Cannabis In general, defective and dangerous products account for thousands of injuries every year in the U.S. The legal rules concerning who is responsible for defective or dangerous products have...
Arthur Cox: European Union: Marketing Of CBD Consumer Products In The EU Addressed By ECJ
The European Court of Justice recently ruled that an EU Member State cannot prohibit the marketing of CBD that has been lawfully produced in another Member State, as to do so would be in breach of EU law on the free movement of goods. Published via the Mondaq...
Husch Blackwell: Operation CBDeceit Marks Beginning of FTC Crackdown on Deceptive CBD Medical Claims While FDA Continues to Issue Warning Letters
On Thursday, December 17th, the Federal Trade Commission (FTC) announced that it was taking action against six companies selling CBD-based products. These companies faced administrative actions by the FTC for “making a wide range of scientifically unsupported claims...
Wasel & Wasel: Commentary on Lebanon’s Medical Cannabis Law – Article 2: Definition of Terms
On 20 April 2020, the Lebanese Parliament passed a law permitting the cultivation, trade, research, and use of medical cannabis. The law covers an array of topics ranging from the types of licenses available to the prevention of monopolization in the industry. In...
Hoban Law: At A Glance – Jersey’s Just-Passed Adult Use Act
On Thursday, December 17, 2020, New Jersey lawmakers approved the “Cannabis Regulatory, Enforcement Assistance, and Marketplace Modernization Act” (“Act”), which next goes to Governor Phil Murphy for his expected signature. Authored By: Steve Schain Under the...Top 200 Cannabis Lawyers
We Support